Breakthrough lung cancer treatment supercharges immune cells with mitochondria – Science Daily
Excerpt:
Researchers from Tongji University School of Medicine and Nantong University published a study in Cancer Biology & Medicine that introduces a novel approach to lung cancer therapy. They investigated whether direct mitochondrial transplantation could enhance the effects of chemotherapy in advanced NSCLC. By combining functional mitochondria with cisplatin, the team aimed to not only improve tumor response but also restore immune vigor inside the tumor microenvironment. Their findings mark a significant step toward integrative treatments that energize both cells and immunity…..
Scientists have found a way to supercharge lung cancer treatment by transplanting healthy mitochondria into tumors, which both boosts immune response and makes chemotherapy far more effective. By combining this novel method with cisplatin, researchers reversed harmful tumor metabolism and empowered immune cells to fight back, all without added toxicity.
While chemotherapy remains a cornerstone of lung cancer treatment, it often weakens the immune system it relies on for long-term control. Now, researchers have found a way to turn this weakness into strength — by transplanting healthy mitochondria into the tumor environment. In advanced non-small cell lung cancer (NSCLC), combining mitochondrial transplantation with cisplatin not only enhanced immune cell infiltration but also reversed tumor metabolism and improved the drug’s effectiveness. This innovative approach transforms mitochondria from mere energy suppliers into active allies in cancer therapy, showing potential to reshape how we treat aggressive lung tumors.
